{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T20:56:29Z","timestamp":1717361789085},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.lungcan.2009.06.009","type":"journal-article","created":{"date-parts":[[2009,7,12]],"date-time":"2009-07-12T08:19:58Z","timestamp":1247386798000},"page":"278-282","source":"Crossref","is-referenced-by-count":10,"title":["Clinical significance of NQO1 C609T polymorphisms after postoperative radiation therapy in completely resected non-small cell lung cancer"],"prefix":"10.1016","volume":"68","author":[{"given":"Si Yeol","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Yun","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heon Joo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Il","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Kwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Soo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-wook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Do","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Shin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Kyung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2009.06.009_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00000658-198701000-00012","article-title":"Patterns of failure in patients with resected stage I and II non-small-cell carcinoma of the lung","volume":"205","author":"Group TLLCS","year":"1987","journal-title":"Ann Surg"},{"key":"10.1016\/j.lungcan.2009.06.009_bib2","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/0003-4975(94)91933-X","article-title":"Management of non-small cell lung cancer with direct mediastinal involvement","volume":"58","author":"Martini","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.lungcan.2009.06.009_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<265::AID-CNCR10>3.0.CO;2-B","article-title":"A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d\u2019Etude et de Traitement des Cancers Bronchiques","volume":"86","author":"Dautzenberg","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2009.06.009_bib4","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/bjc.1996.413","article-title":"The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party","volume":"74","author":"Stephens","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2009.06.009_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/jnci\/85.4.299","article-title":"Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. The Lung Cancer Study Group","volume":"85","author":"Feld","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lungcan.2009.06.009_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0169-5002(03)00027-8","article-title":"Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan","volume":"40","author":"Lin","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2009.06.009_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lungcan.2003.11.019","article-title":"Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy","volume":"44","author":"Ryu","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2009.06.009_bib8","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1378\/chest.127.3.978","article-title":"ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer","volume":"127","author":"Simon","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2009.06.009_bib9","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2009.06.009_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0006-2952(94)00333-5","article-title":"Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism","volume":"49","author":"Cadenas","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.lungcan.2009.06.009_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-2797(91)90029-7","article-title":"Molecular mechanisms of quinone cytotoxicity","volume":"80","author":"O\u2019Brien","year":"1991","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.lungcan.2009.06.009_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0009-2797(00)00199-X","article-title":"NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms","volume":"129","author":"Ross","year":"2000","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.lungcan.2009.06.009_bib13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0006-2952(03)00013-3","article-title":"Cytotoxicity and apoptosis of benzoquinones: redox cycling, cytochrome c release, and BAD protein expression","volume":"65","author":"Tudor","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.lungcan.2009.06.009_bib14","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1073\/pnas.052706799","article-title":"NQO1 stabilizes p53 through a distinct pathway","volume":"99","author":"Asher","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.lungcan.2009.06.009_bib15","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1073\/pnas.021558898","article-title":"Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1","volume":"98","author":"Asher","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.lungcan.2009.06.009_bib16","first-page":"7293","article-title":"Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells","volume":"50","author":"Siegel","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2009.06.009_bib17","first-page":"7483","article-title":"Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells","volume":"50","author":"Siegel","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2009.06.009_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3727\/095535491820873164","article-title":"The role of NAD(P)H: quinone reductase (EC 1.6.99.2.DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9","volume":"3","author":"Walton","year":"1991","journal-title":"Cancer Commun"},{"key":"10.1016\/j.lungcan.2009.06.009_bib19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ijc.2910590211","article-title":"DT-diaphorase as a determinant of sensitivity to adriamycin in non-small-cell lung-cancer cell lines","volume":"59","author":"Kasahara","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2009.06.009_bib20","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0960-894X(98)00069-9","article-title":"Indolequinone antitumor agents: relationship between quinone structure and rate of metabolism by recombinant human NQO1","volume":"8","author":"Beall","year":"1998","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.lungcan.2009.06.009_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00689804","article-title":"NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues","volume":"12","author":"Belinsky","year":"1993","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.lungcan.2009.06.009_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s101470200013","article-title":"NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese","volume":"7","author":"Hamajima","year":"2002","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.lungcan.2009.06.009_bib23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0076-6879(90)86122-C","article-title":"DT-diaphorase: purification, properties, and function","volume":"186","author":"Lind","year":"1990","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.lungcan.2009.06.009_bib24","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/0006-2952(92)90694-E","article-title":"DT-diaphorase and cancer chemotherapy","volume":"43","author":"Riley","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.lungcan.2009.06.009_bib25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0891-5849(00)00306-3","article-title":"Regulation of genes encoding NAD(P)H:quinone oxidoreductases","volume":"29","author":"Jaiswal","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.lungcan.2009.06.009_bib26","series-title":"Oxidative Stress and Signal Transduction","article-title":"Gene expression of DT diaphorase (NQO1) in cancer cells","author":"Radjendirane","year":"1997"},{"key":"10.1016\/j.lungcan.2009.06.009_bib27","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1593\/neo.07397","article-title":"Upregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive beta-lapachone on cancer cells","volume":"9","author":"Choi","year":"2007","journal-title":"Neoplasia"},{"key":"10.1016\/j.lungcan.2009.06.009_bib28","first-page":"3045","article-title":"Association of the NAD(P)H:quinone oxidoreductase 609C\u2192T polymorphism with a decreased lung cancer risk","volume":"59","author":"Chen","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2009.06.009_bib29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/009841099157287","article-title":"NAD(P)H:quinone oxidoreductase polymorphism and lung cancer in Taiwan","volume":"58","author":"Lin","year":"1999","journal-title":"J Toxicol Environ Health A"},{"key":"10.1016\/j.lungcan.2009.06.009_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0169-5002(01)00243-4","article-title":"Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population","volume":"34","author":"Lewis","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2009.06.009_bib31","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/sj.bjc.6601779","article-title":"Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations","volume":"90","author":"Menzel","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2009.06.009_bib32","doi-asserted-by":"crossref","first-page":"14060","DOI":"10.1074\/jbc.M111576200","article-title":"Interaction of the molecular chaperone Hsp70 with human NAD(P)H:quinone oxidoreductase 1","volume":"277","author":"Anwar","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lungcan.2009.06.009_bib33","first-page":"797","article-title":"NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity","volume":"52","author":"Traver","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2009.06.009_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/bjc.1997.11","article-title":"Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase)","volume":"75","author":"Traver","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2009.06.009_bib35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00008571-199902000-00015","article-title":"Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1","volume":"9","author":"Siegel","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.lungcan.2009.06.009_bib36","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/bjc.1996.477","article-title":"A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity","volume":"74","author":"Ross","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2009.06.009_bib37","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/bjc.1995.373","article-title":"Presence of a heterozygous substitution and its relationship to DT-diaphorase activity","volume":"72","author":"Kuehl","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2009.06.009_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1017900810837","article-title":"Radiation induced oxidative stress. I. Studies in Ehrlich solid tumor in mice","volume":"223","author":"Agrawal","year":"2001","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.lungcan.2009.06.009_bib39","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0006-2952(01)00769-9","article-title":"Genotyping of NAD(P)H:quinone oxidoreductase (NQO1) in a panel of human tumor xenografts: relationship between genotype status. NQO1 activity and the response of xenografts to mitomycin C chemotherapy in vivo (1)","volume":"62","author":"Phillips","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.lungcan.2009.06.009_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00008571-200201000-00005","article-title":"Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C","volume":"12","author":"Fleming","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.lungcan.2009.06.009_bib41","first-page":"1119","article-title":"Evaluation of NQO1 gene expression and variant allele in human NSCLC tumors and matched normal lung tissue","volume":"21","author":"Kolesar","year":"2002","journal-title":"Int J Oncol"},{"key":"10.1016\/j.lungcan.2009.06.009_bib42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/mol.59.2.263","article-title":"Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1","volume":"59","author":"Siegel","year":"2001","journal-title":"Mol Pharmacol"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950020900333X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950020900333X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T13:58:36Z","timestamp":1589983116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016950020900333X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S016950020900333X"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2009.06.009","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}